We report a case of a 83-year-old woman with the initial diagnosis of an occult invasive lobular breast carcinoma due to gastrointestinal metastasis with an entervesical fistula.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1055/a-1329-3855 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Colovesical Fistula in a Kidney Transplant Patient: A Fatal Outcome.
Cureus
October 2024
Urology, Faculty of Medicine of São José do Rio Preto, São José do Rio Preto, BRA.
Colovesical fistula (CVF) is a rare but potentially serious condition characterized by abnormal communication between the colon and the bladder. This pathology can result from inflammatory diseases, malignancies, or previous surgical interventions, with a significant impact on the patient's quality of life. CVF is associated with high morbidity and mortality rates, particularly in immunosuppressed individuals, such as renal transplant recipients, due to their increased susceptibility to infections and surgical complications.
View Article and Find Full Text PDFReviving the poppy seed test for the diagnosis of colovesical fistula: A case report from a single rural center experience.
Clin Case Rep
October 2024
Department of Urology Northeast Health Wangaratta Wangaratta Victoria Australia.
Key Clinical Message: The poppy seed test is a valuable, cost-effective, and sensitive initial diagnostic investigation to identify the presence of colovesical fistula, particularly for clinicians in remote or rural areas with lack of access to specialist radiologic, endoscopic, surgical, or urological support. The poppy seed test therefore may act as a bridge toward the commencement of appropriate referral pathways for the management of colovesical fistula.
Abstract: The diagnosis of colovesical fistula is resource intensive, often requiring a combination of radiological investigation and endoscopy.
Robot-assisted radical nephroureterectomy using the KangDuo Surgical Robot-01 System versus the da Vinci System: a multicenter prospective randomized controlled trial.
Int Braz J Urol
September 2024
Department of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Article Synopsis
- - The study compares the safety and effectiveness of the KangDuo-Surgical Robot-01 (KD-SR-01) and the da Vinci (DV) systems for robot-assisted radical nephroureterectomy (RARNU) through a multicenter trial involving 58 patients from March 2022 to September 2023.
- - Results showed no significant differences in operative metrics and outcomes between the two systems, with both achieving 100% success rates and no serious complications during a four-week follow-up period.
- - The KD-SR-01 system is deemed safe and effective for RARNU, although the authors recommend further research with larger sample sizes and extended follow-up for more comprehensive results.
Outcomes of surgical treatment for enterovesical fistula in Crohn's disease.
Nagoya J Med Sci
May 2024
Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Enterovesical fistula (EVF) in Crohn's disease (CD) often does not improve with medical treatment and requires surgical treatment. The surgical treatment strategy for EVF in CD is definitive resection of the intestinal tract side, and performing a leak test using dye injection into the bladder after EVF dissection to determine the appropriate surgical procedure for the bladder side. This study aimed to evaluate the outcomes of surgical treatment for EVF in CD.
View Article and Find Full Text PDFEnterovesical Fistula Revealing Crohn's Disease: A Case Report.
Cureus
March 2024
Urology, Mohammed VI University Hospital, Oujda, MAR.
Crohn's disease is an inflammatory bowel disease of unknown etiology. It is characterized by intra- and extra-intestinal complications. It is a frequent cause of uroenteric fistulas.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!